Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oncogenic reg IV is a novel prognostic marker for glioma patient survival.

Diagnostic pathology·2012

Same author

Two-year outcome of high-risk benign prostate hyperplasia patients treated with transurethral prostate resection by plasmakinetic or conventional procedure.

Urology·2012

Same author

Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: a meta-analysis.

Journal of cardiovascular pharmacology·2012

Same author

Tailored design of architecturally controlled Pt nanoparticles with huge surface areas toward superior unsupported Pt electrocatalysts.

ACS applied materials & interfaces·2012

Same author

Primary non-Hodgkin's lymphoma of the skull base: a case report and literature review.

Clinical neurology and neurosurgery·2012

Same author

Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.

Neurobiology of disease·2012

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Mesenchymal stem cells targeting the GVHD.

Liang Wang¹, Robert ChunHua Zhao

¹Center of Tissue Engineering, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100005, China.

Science in China. Series C, Life Sciences

|July 31, 2009

Summary

This summary is machine-generated.

Acute graft-versus-host disease (GVHD) is a serious complication following stem cell transplants. Mesenchymal stem cells (MSCs) show promise in treating steroid-refractory acute GVHD, offering a potential new therapeutic avenue.

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Related Experiment Videos

Last Updated: Jun 21, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Area of Science:

Immunology
Hematology
Cellular Therapy

Background:

Acute graft-versus-host disease (GVHD) is a significant complication post-allogeneic hematopoietic stem cell transplant (HSCT), affecting 35-50% of recipients.
Steroid-refractory acute GVHD carries high morbidity and mortality, with limited effective salvage therapies.
Current treatments for refractory GVHD often lead to severe immunosuppression and life-threatening infections.

Purpose of the Study:

To evaluate the therapeutic potential of mesenchymal stem cells (MSCs) for steroid-refractory acute GVHD.
To explore the immunomodulatory effects of MSCs in the context of GVHD treatment.
To assess the clinical efficacy and safety of MSCs as a cellular immunosuppressant therapy.

Main Methods:

Clinical investigation of MSCs in patients with steroid-refractory acute GVHD.
Assessment of patient responses and outcomes following MSC administration.
Evaluation of the immunosuppressive properties of MSCs in vivo.

Main Results:

Encouraging responses observed in multiple studies involving MSCs for steroid-refractory acute GVHD.
MSC therapy demonstrated potential as an effective treatment option.
The immunosuppressive capacity of MSCs is becoming increasingly evident in clinical applications.

Conclusions:

Mesenchymal stem cells (MSCs) represent a promising therapeutic strategy for steroid-refractory acute GVHD.
MSC-based therapy offers a potentially safer alternative to conventional treatments, mitigating severe immunosuppression.
Further clinical research is warranted to fully establish the role of MSCs in GVHD management.